Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platform
Non-Regulatory
2023-09-11
• The primary endpoint of HiSCR75 at week 16 did not meet statistical significance in...[read more]
event
9 Sep
Annual Congress of the European Association of Nuclear Medicine (EANM) September 9-13, 2023, Vienna, Austria
event
20 Oct
ESMO 2023 European Society for Medical Oncology (ESMO) Annual Meeting, October 20-24, 2023, Madrid, Spain
event
30 Oct
HER2-Targeted Therapies Summit 2023 October 30-November 1, 2023, Boston, USA
There are currently no posts in the reports and events archive.
Affibody has a broad pipeline based on the Affibody® technology with multiple clinical assets The pipeline is designed to demonstrate the value and versatility of the technology platform.
It is the competence and the engagement of all coworkers that make Affibody an inspiring and exciting place to work at. We know we reach much further in innovation, efficiency, and quality by having a work place where we as coworkers care for each other, are ambitious and know and value our own contribution to the end result.
